Linc

What is Linc?

Linc is an investment firm based in Stockholm, Sweden, specializing in venture capital investments.

The firm exhibits a strong focus on the life science and health-tech sectors, positioning itself as a significant player in these industries. Linc targets startup and growth-stage companies, with a particular interest in the Nordic Life Science industry, which encompasses pharmaceutical and medical technology companies.

Their investment strategy indicates a preference for engaging with product-oriented companies.

For pharmaceutical development, Linc usually enters at an early stage, demonstrating their willingness to support the high-risk, high-reward aspect of early drug development. Conversely, when it comes to medical technology investments, they tend to get involved with more mature operations, suggesting a balanced approach to risk within their portfolio. The firm seeks to create value and contribute to improved quality of life through their investments, underlining a commitment to not only financial returns but also positive societal impact within the Life Science domain.

Linc's portfolio consists of both listed and unlisted companies, indicating a flexible investment approach that accommodates different growth and development stages of their portfolio companies. The website highlights Linc's investment philosophy, involvement as an active owner, and their track record, as well as their commitment to sustainability. In addition to providing financial capital, Linc emphasizes their role in governance, guiding their portfolio companies by participating in board work and supporting their strategic development.